Europe · Markets & Finance · El Economista

Shionogi compra IntraBio por 2.000 millones y refuerza su cartera de enfermedades raras

Published by El Economista · Spain 11 h ago

La japonesa Shionogi ha acordado adquirir la estadounidense IntraBio por 2.000 millones de dólares (1.783 millones), en una operación que amplía su presencia en enfermedades…

Read the full article on El Economista Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.eleconomista.es)

Also worth reading

This is Money

Broadband finds a saviour: BT's rescue of TalkTalk is far from perfect - but it could be a whole lot worse, says ALEX BRUMMER

City A.M.

Corporate Bitcoin buying accelerates as Strategy, Strive and Metaplanet expand BTC treasuries

Proactive Investors

Shionogi compra IntraBio por 2.000 millones y refuerza su cartera de enfermedades raras

Share

Also worth reading

Broadband finds a saviour: BT's rescue of TalkTalk is far from perfect - but it could be a whole lot worse, says ALEX BRUMMER

Tories say £10bn ‘Britannia Shield’ would fend off missiles

Wall Street banks launch record $60bn chip deal for Broadcom and Anthropic

Nasdaq hits record as dollar and Treasury yields climb, oil prices ease

Corporate Bitcoin buying accelerates as Strategy, Strive and Metaplanet expand BTC treasuries

The-Break down: BT picks over the bones of TalkTalk. Here's what it really means